# Transposagen Biopharmaceuticals, Inc. — Form D

Transposagen Biopharmaceuticals, Inc. of LEXINGTON, KY, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-20. The offering totals $1.0M, of which $725K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-12-20
- Form: D
- Accession: 0000911959-11-000027
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $725K
- Remaining: $275K
- Minimum investment: $25K
- Investors: 7
- Date of first sale: 2011-12-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-170391

## Issuer

- Name: Transposagen Biopharmaceuticals, Inc.
- CIK: 0001537601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 145 GRAHAM AVENUE, LEXINGTON, KY, 40506
- Phone: 859-428-8561

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Eric M Ostertag | Director | Lexington, KY |
| Eric M Ostertag | Executive Officer | Lexington, KY |
| Joseph M Ruiz | Executive Officer | Lexington, KY |
| Eric M. Ostertag | Director | Lexington, KY |
| Eric M. Ostertag | Executive Officer | Lexington, KY |
| Joseph M. Ruiz | Executive Officer | Lexington, KY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-07-18](https://search.stillhousedata.com/formd/0000911959-12-000022) | D | $1.3M | $355K |

## More

- [CIK 1537601 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1537601&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000911959-11-000027.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.